Recent Cancer Treatment Research for November 2024
Undifferentiated Pleomorphic Sarcoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Vulvar Squamous Cell Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology, Obstetrics/Gynecology
| Metastatic Cutaneous Squamous Cell Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| Lung Adenocarcinoma - Epidemiology Forecast - 2032
Topics: Cancer Treatment, Drug Discovery
| South and Central America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infecti
Topics: Antibody Technologies, Cancer Treatment, Autoimmune, COVID-19/Coronavirus, Hospitals & Clinics, Infectious Diseases
Regions: Central America
| 2022-2029 Global Cancer Biomarkers Professional Market Research Report, Analysis from Perspective of Segmentation (Competitor Landscape, Type, Application, and Geography)
Topics: Biomarkers, Cancer Treatment, Oncology/Hematology
Regions: Global
| Middle East and Africa Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious
Topics: Antibody Technologies, Cancer Treatment, Autoimmune, COVID-19/Coronavirus, Hospitals & Clinics, Infectious Diseases
Regions: Africa, Middle East
| Rat Model Market Size By Rat Type (Inbred, Outbred, Knockout, Hybrid), By Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer), By Application (Research & Development, {Infectious Disease, Immunological Disease, Cancer, Car
Topics: Stem Cell, DNA Sequencing, Diabetes, Cancer Treatment, Veterinary Health
| Cervical Cancer Diagnostics Global Market Report 2022
Including: 1) By Diagnostic Test: Pap Smear Test; HPV Test; Colposcopy; Biopsy and Endocervical Curettage; Other Diagnostic Tests
2) By End User: Hospitals; Specialty Clinics; Cancer and Radiation The
Topics: Adults (18-55), Cancer Treatment, Hospitals & Clinics, Hematology & Oncology, Gynecological Devices, Women's Health, Obstetrics/Gynecology
Regions: Global
| 2022-2026 Albania Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Albania
| 2022-2026 Finland Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Finland
| 2022-2026 Netherlands Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunit
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Netherlands
| Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer, Urothelial/Bladder Cancer), By Technology (Cleavable, Non-cleavable Linker, Linkerless), And Segment Forecasts, 2022 - 2030
Topics: Antibody Technologies, Cancer Treatment, Oncology/Hematology
| 2022-2026 Iceland Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volum
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Iceland
| 2022-2026 Iceland Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Iceland
| Pain Management Devices Market by Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) & Region (NA, Europe, APAC) - Global Forecasts to 2026
Topics: Pain, Cancer Treatment, Infusion Products, Over-the-Counter Drugs, Prescription Drugs, CNS/Neurology, Oncology/Hematology
Regions: Asia, Europe, Global
| Middle East and Turkey Chronic Liver Disease (CLD) Therapeutics Market, by Disease Type (Hepatitis, Alcohol Induced Liver Disease, Liver Cancer, Fatty Liver Disease, and Others), by Drug Class (Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobuli
Topics: Antibody Technologies, Hepatitis, Cancer Treatment, Hospitals & Clinics, Vaccines, Drug Discovery, Clinical Nutrition
Regions: Egypt, Turkey, Israel, Saudi Arabia, United Arab Emirates, Middle East
| 2022-2026 Israel Cancer Diagnostics Market Segmentation Analysis and Database: Supplier Strategies, Emerging Tumor Markers, Volume and Sales Forecasts, Technology and Instrumentation Review
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Israel
| 2022-2026 Israel Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Israel
| 2022 Europe Cancer Diagnostics Market Shares in France, Germany, Italy, Spain, UK - Competitive Analysis of Leading and Emerging Market Players
Topics: Cancer Treatment, Hematology & Oncology
Regions: France, Germany, Italy, Spain, United Kingdom, Europe
| 2022-2026 Australia Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunitie
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Australia
| 2022-2026 Bolivia Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Bolivia
| South America Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Labor
Topics: Cancer Treatment, COVID-19/Coronavirus, Hematology & Oncology, Microbiology & Virology, Gynecological Devices, Obstetrics/Gynecology
Regions: South America
| Hormone Sensitive Advanced Prostate Cancer - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Oncology/Hematology, Men's Health
| Nephroblastoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery
| Nasopharyngeal Carcinoma - Market Insight, Epidemiology and Market Forecast -2032
Topics: Cancer Treatment, Drug Discovery, Oncology/Hematology
| HPV-Induced Cancers - Market Insight, Epidemiology and Market Forecast -2032
Topics: AIDS, HIV & STDs, Cancer Treatment, Drug Discovery, Obstetrics/Gynecology
| Acute Myelogenous Leukemia (AML) - Epidemiology Forecast - 2032
Topics: Cancer Treatment, Oncology/Hematology
| Advanced Breast Cancer In Premenopausal Women - Epidemiology Forecast - 2032
Topics: Cancer Treatment, Drug Discovery, Women's Health, Oncology/Hematology
| Cancer Biomarkers Market, by Biomarker Type (Protein Biomarkers, Genetic Biomarkers and Other Cancer Biomarkers), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Kidney Cancer, Liver Cancer and Other Cancers), by End User (Hospitals, Academic
Topics: Biomarkers, Cancer Treatment, Hospitals & Clinics, Oncology/Hematology, Men's Health
| Cancer Diagnostics Market, By Test Type (Tumor Biomarkers Tests (PSA Tests, CTC Tests, AFP Tests, CA-19 Tests, HER2 Tests, BRCA Tests, ALK Tests, CEA Tests, EGFR Mutation Tests, KRAS Mutation Tests, Others)), Imaging (Ultrasound, Mammography, MRI Scan, PE
Topics: Biomarkers, Cancer Treatment, Mammography, NMR & MRI, Ultrasonography, Oncology/Hematology
| 2022-2026 India Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: India
| 2022-2026 Canada Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Canada
| 2022-2026 China Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: China
| 2022-2026 Europe Cancer Diagnostics Market Database for 38 Countries - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Europe
| 2022-2026 Europe Cancer Diagnostics Market Database for France, Germany, Italy, Spain, UK - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: France, Germany, Italy, Spain, United Kingdom, Europe
| 2022-2026 Global Cancer Diagnostics Market Database for the USA, Europe, Japan - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Japan, United States, Europe, Global
| 2022-2026 India Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: India
| 2022-2026 Latin America Cancer Diagnostics Market Database for 22 Countries - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: South America
| 2022-2026 North America Cancer Diagnostics Market Database for the USA, Canada, Mexico - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Canada, United States, Mexico, North America
| 2022-2026 Russia Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: Russia
| 2022-2026 UK Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: United Kingdom
| 2022-2026 US Cancer Diagnostics Market Database - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
Topics: Biomarkers, Cancer Treatment, Hematology & Oncology, Oncology/Hematology
Regions: United States
| Europe Molecular Genetic, Cancer, Forensic and Paternity Testing Market: France, Germany, Italy, Spain, UK-Supplier Sales and Shares, Volume and Sales Segment Forecasts, Competitive Analysis, Emerging Technologies, Latest Instrumentation, Growth Opportuni
Topics: Instrumentation & Equipment, Cancer Treatment, Molecular Diagnostics
Regions: France, Germany, Italy, Spain, United Kingdom, Europe
| North America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases
Topics: Antibody Technologies, Cancer Treatment, Autoimmune, COVID-19/Coronavirus
Regions: North America
| 2022-2026 Cuba Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume a
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: Cuba
| 2022-2026 Cuba Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: Cuba
| 2022-2026 Europe Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests in France, Germany, Italy, Spain, UK High-Growth Opportunities for Suppliers, Competitive
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: France, Germany, Italy, Spain, United Kingdom, Europe
| 2022-2026 France Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume
Topics: Instrumentation & Equipment, Cancer Treatment, Clinical Chemistry, Immunoassays
Regions: France
| 2022-2026 France Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities f
Topics: Instrumentation & Equipment, Biomarkers, Cancer Treatment, Hematology & Oncology
Regions: France
|
Prev | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
